Literature DB >> 371884

Antibodies to maize in patients with Crohn's disease, ulcerative colitis and coeliac disease.

I W Davidson, R S Lloyd, P J Whorwell, R Wright.   

Abstract

The incidence of antibodies to maize using an immunofluorescent technique has been found to be 14% in controls, 33% in Crohn's disease, 50% in ulcerative colitis and 44% in coeliac disease. This result indicates that humoral immunity to maize is probably unimportant in the pathogenesis of Crohn's disease. The similar incidence of antibodies in the inflammatory bowel disease and coeliac groups suggests absorption of dietary antigen secondary to an increased mucosal permeability.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 371884      PMCID: PMC1537589     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  6 in total

1.  Isolation of reovirus-like agents from patients with Crohn's disease.

Authors:  P J Whorwell; C A Phillips; W L Beeken; P K Little; K D Roessner
Journal:  Lancet       Date:  1977-06-04       Impact factor: 79.321

2.  Antibodies to gluten and reticulin in gastrointestinal diseases.

Authors:  K P Eterman; T E Feltkamp
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

3.  Electron microscopic studies of viral agents in Crohn's disease.

Authors:  G L Gitnick; V J Rosen
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

4.  Circulating antibodies to bovine albumin in ulcerative colitis and Crohn's disease. Characterization of the antibody response.

Authors:  K R Falchuk; K J Isselbacher
Journal:  Gastroenterology       Date:  1976-01       Impact factor: 22.682

5.  Bacterial variants: etiologic agent in Crohn's disease?

Authors:  K Parent; P D Mitchell
Journal:  Gastroenterology       Date:  1976-08       Impact factor: 22.682

6.  Breakfast and Crohn's disease.

Authors:  A H James
Journal:  Br Med J       Date:  1977-04-09
  6 in total
  8 in total

1.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.

Authors:  C L Sutton; H Yang; Z Li; J I Rotter; S R Targan; J Braun
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.

Authors:  G A Neil; R W Summers; B A Cheyne; C Capenter; W L Huang; G S Kansas; T J Waldschmidt
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

3.  Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.

Authors:  M H Giaffer; A Clark; C D Holdsworth
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

4.  Detection of Candida albicans by culture, serology and PCR in clinical specimens from patients with ulcerative colitis: re-evaluation of an old hypothesis with a new perspective.

Authors:  A Kalkanci; C Tuncer; B Degertekin; A Eren; S Kustimur; M N Ilhan; A Dursun
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

5.  Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.

Authors:  H McKenzie; J Main; C R Pennington; D Parratt
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

6.  Serological markers to differentiate between ulcerative colitis and Crohn's disease.

Authors:  M Oudkerk Pool; G Bouma; S G Meuwissen; B M von Blomberg; J P van de Merwe; W L Devillé; J C Fonk; A S Peña
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

Review 7.  Current understanding of fungal microflora in inflammatory bowel disease pathogenesis.

Authors:  David Underhill; Jonathan Braun
Journal:  Inflamm Bowel Dis       Date:  2008-08       Impact factor: 5.325

8.  Serum agglutinins to Eubacterium and Peptostreptococcus species in Crohn's and other diseases.

Authors:  F Wensinck; J P Van de Merwe
Journal:  J Hyg (Lond)       Date:  1981-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.